RHUMBLINE ADVISERS - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$188,000
-11.7%
41,774
-3.3%
0.00%
Q4 2020$213,000
-4.5%
43,200
+15.0%
0.00%
Q3 2020$223,000
+84.3%
37,570
-17.3%
0.00%
Q2 2020$121,000
+98.4%
45,453
+45.8%
0.00%
Q1 2020$61,000
-72.3%
31,1840.0%0.00%
Q4 2019$220,000
-27.4%
31,184
+1.1%
0.00%
-100.0%
Q3 2019$303,000
-14.2%
30,835
-0.2%
0.00%0.0%
Q2 2019$353,000
+52.2%
30,892
+34.0%
0.00%
Q1 2019$232,00023,0610.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders